BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36908489)

  • 1. Reporting of Inter Fraction Dose Variations of Organs at Risk in Computed Tomography-Guided High Dose Rate Intracavitary Brachytherapy in Carcinoma Cervix.
    Nandi M; Pokala N; Perumareddy V; Sarkar S; Chanda S
    J Med Phys; 2022; 47(4):394-397. PubMed ID: 36908489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix.
    Patil G; Br KK; Narayanan G
    Cureus; 2022 Jan; 14(1):e21503. PubMed ID: 35223279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
    Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
    J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of conformal computed tomography (CT)-based intracavitary brachytherapy (ICBT) for locally advanced cervical cancer: a single institution's experience.
    Tharavichitkul E; Mayurasakorn S; Lorvidhaya V; Sukthomya V; Wanwilairat S; Lookaew S; Pukanhaphan N; Chitapanarux I; Galalae R
    J Radiat Res; 2011; 52(5):634-40. PubMed ID: 21952319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer.
    Pasha T; Hassan HN; Radhakrishna N; N MS; Varghese AS; Viswanath L; Valuvil NB; S S; H B G; Khaleel I; Palled SR; Thimmaiah N
    J Contemp Brachytherapy; 2021 Dec; 13(6):627-632. PubMed ID: 35079248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfraction Dose Variations in Organs at Risk during CT-Based High-Dose-Rate Brachytherapy in Locally Advanced Carcinoma Cervix: An Early Experience of a Tertiary Care Center.
    Sharma N; Semwal MK; Purkayastha A
    J Med Phys; 2018; 43(2):136-140. PubMed ID: 29962692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interfraction physical dose variations in high-dose-rate brachytherapy for carcinoma cervix based on computed tomography image dataset to find the compatibility of the first fraction plan to treat successive fractions.
    Yadav S; Singh OP; Choudhary S; Saroj DK; Maurya AK; Yogi V
    J Cancer Res Ther; 2019; 15(6):1304-1308. PubMed ID: 31898664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
    Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
    Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.
    Yin G; Wang P; Lang J; Tian Y; Luo Y; Fan Z; Tam KY
    J Contemp Brachytherapy; 2016 Jun; 8(3):221-32. PubMed ID: 27504132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Yan J; Zhu J; Chen K; Yu L; Zhang F
    Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of two-dimensional radiography and three dimensional computed tomography based dose-volume parameters for high-dose-rate intracavitary brachytherapy of cervical cancer: a prospective study.
    Madan R; Pathy S; Subramani V; Sharma S; Mohanti BK; Chander S; Thulkar S; Kumar L; Dadhwal V
    Asian Pac J Cancer Prev; 2014; 15(11):4717-21. PubMed ID: 24969909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric analysis of the effects of the bladder volume on organs at risk (OAR) in high-dose-rate intracavitary brachytherapy in carcinoma cervix - an institutional study.
    Sharma AD; Poddar J; Suryanarayan K U; Shah SP; Parikh A; Mehta V; Phys M; Kumar T; Phys M
    J Contemp Brachytherapy; 2018 Feb; 10(1):26-31. PubMed ID: 29619053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of different dose prescription schedules on EQD
    Kumar M; Thangaraj R; Alva RC; Koushik K; Ponni A; Achar JM
    J Contemp Brachytherapy; 2019 Apr; 11(2):189-193. PubMed ID: 31139229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
    Kim RY; Shen S; Duan J
    Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer.
    Wang X; Li J; Wang P; Yuan K; Yin G; Wan B
    J Contemp Brachytherapy; 2016 Apr; 8(2):122-7. PubMed ID: 27257416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude and Implications of Interfraction Variations in Organ Doses during High Dose Rate Brachytherapy of Cervix Cancer: A CT Based Planning Study.
    Chakraborty S; Patel FD; Patil VM; Oinam AS; Sharma SC
    ISRN Oncol; 2014; 2014():687365. PubMed ID: 24693451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
    J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of Intracavitary Applicator Placement for HDR Brachytherapy of Cervix Cancer.
    Balsdon A; Timotin E; Hunter R; Diamond K
    J Med Imaging Radiat Sci; 2019 Sep; 50(3):441-448. PubMed ID: 31311722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.